Remdesivir-Related Cardiac Adverse Effects in COVID-19 Patients: A Case-Control Study.
Fatemah AbedipourHossein Hadavand MirzaeiHossein AnsariNeda EhsanzadehAmin RashkiMohammad Mahdi VahediAsma RashkiPublished in: Drug research (2024)
Our findings indicated that most of the COVID-19 patients suffered from sinus bradycardia, and the distribution of complications was more pronounced in men than in women. The mean age in the group with complications was higher than the group without complications. Smoking was found to be associated with the occurrence of cardiovascular complications and the mean changes of Bilirubin and ALKP before and after treatment were significantly different in the groups with and without cardiovascular complications.